Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Planagumà J[au]:

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Malviya M et al. Ann Clin Transl Neurol. (2017)

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder. Martinez-Hernandez E et al. JAMA Neurol. (2016)

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Planagumà J et al. Brain. (2015)

Search results

Items: 29

1.

LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory.

Petit-Pedrol M, Sell J, Planagumà J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C.

Brain. 2018 Nov 1;141(11):3144-3159. doi: 10.1093/brain/awy253.

PMID:
30346486
2.

Human Autoantibodies against the AMPA Receptor Subunit GluA2 Induce Receptor Reorganization and Memory Dysfunction.

Haselmann H, Mannara F, Werner C, Planagumà J, Miguez-Cabello F, Schmidl L, Grünewald B, Petit-Pedrol M, Kirmse K, Classen J, Demir F, Klöcker N, Soto D, Doose S, Dalmau J, Hallermann S, Geis C.

Neuron. 2018 Oct 10;100(1):91-105.e9. doi: 10.1016/j.neuron.2018.07.048. Epub 2018 Aug 23.

PMID:
30146304
3.

NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors.

Ladépêche L, Planagumà J, Thakur S, Suárez I, Hara M, Borbely JS, Sandoval A, Laparra-Cuervo L, Dalmau J, Lakadamyali M.

Cell Rep. 2018 Jun 26;23(13):3759-3768. doi: 10.1016/j.celrep.2018.05.096.

4.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

PMID:
29703767
5.

NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N.

Ann Clin Transl Neurol. 2017 Oct 3;4(11):768-783. doi: 10.1002/acn3.444. eCollection 2017 Nov.

6.

Phosphorylation of filamin A regulates chemokine receptor CCR2 recycling.

Pons M, Izquierdo I, Andreu-Carbó M, Garrido G, Planagumà J, Muriel O, Del Pozo MA, Geli MI, Aragay AM.

J Cell Sci. 2017 Jan 15;130(2):490-501. doi: 10.1242/jcs.193821. Epub 2016 Dec 1.

7.

Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome.

Sabater L, Planagumà J, Dalmau J, Graus F.

J Neuroinflammation. 2016 Sep 1;13(1):226. doi: 10.1186/s12974-016-0689-1.

8.

Ephrin-B2 prevents N-methyl-D-aspartate receptor antibody effects on memory and neuroplasticity.

Planagumà J, Haselmann H, Mannara F, Petit-Pedrol M, Grünewald B, Aguilar E, Röpke L, Martín-García E, Titulaer MJ, Jercog P, Graus F, Maldonado R, Geis C, Dalmau J.

Ann Neurol. 2016 Sep;80(3):388-400. doi: 10.1002/ana.24721. Epub 2016 Aug 2.

9.

Human neurexin-3α antibodies associate with encephalitis and alter synapse development.

Gresa-Arribas N, Planagumà J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, Simabukuro MM, Armangué T, Martínez-Hernández E, Graus F, Dalmau J.

Neurology. 2016 Jun 14;86(24):2235-42. doi: 10.1212/WNL.0000000000002775. Epub 2016 May 11.

10.

Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.

Martinez-Hernandez E, Ariño H, McKeon A, Iizuka T, Titulaer MJ, Simabukuro MM, Lancaster E, Petit-Pedrol M, Planagumà J, Blanco Y, Harvey RJ, Saiz A, Graus F, Dalmau J.

JAMA Neurol. 2016 Jun 1;73(6):714-20. doi: 10.1001/jamaneurol.2016.0133.

11.

Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Armangué T, Sabater L, Torres-Vega E, Martínez-Hernández E, Ariño H, Petit-Pedrol M, Planagumà J, Bataller L, Dalmau J, Graus F.

JAMA Neurol. 2016 Apr;73(4):417-24. doi: 10.1001/jamaneurol.2015.4607.

12.

Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Planagumà J, Leypoldt F, Mannara F, Gutiérrez-Cuesta J, Martín-García E, Aguilar E, Titulaer MJ, Petit-Pedrol M, Jain A, Balice-Gordon R, Lakadamyali M, Graus F, Maldonado R, Dalmau J.

Brain. 2015 Jan;138(Pt 1):94-109. doi: 10.1093/brain/awu310. Epub 2014 Nov 11.

13.

Combining NK cells and mAb9.2.27 to combat NG2-dependent and anti-inflammatory signals in glioblastoma.

Kmiecik J, Gras Navarro A, Poli A, Planagumà JP, Zimmer J, Chekenya M.

Oncoimmunology. 2014 Jan 1;3(1):e27185.

14.

A new non-canonical pathway of Gα(q) protein regulating mitochondrial dynamics and bioenergetics.

Benincá C, Planagumà J, de Freitas Shuck A, Acín-Perez R, Muñoz JP, de Almeida MM, Brown JH, Murphy AN, Zorzano A, Enríquez JA, Aragay AM.

Cell Signal. 2014 May;26(5):1135-46. doi: 10.1016/j.cellsig.2014.01.009. Epub 2014 Jan 18.

15.

Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.

Poli A, Wang J, Domingues O, Planagumà J, Yan T, Rygh CB, Skaftnesmo KO, Thorsen F, McCormack E, Hentges F, Pedersen PH, Zimmer J, Enger PØ, Chekenya M.

Oncotarget. 2013 Sep;4(9):1527-46.

16.

Filamin A-hinge region 1-EGFP: a novel tool for tracking the cellular functions of filamin A in real-time.

Planagumà J, Minsaas L, Pons M, Myhren L, Garrido G, Aragay AM.

PLoS One. 2012;7(8):e40864. doi: 10.1371/journal.pone.0040864. Epub 2012 Aug 1.

17.

Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma.

Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M.

Acta Neuropathol. 2011 Oct;122(4):495-510. doi: 10.1007/s00401-011-0867-2. Epub 2011 Aug 24.

18.

Targeting the NG2/CSPG4 proteoglycan retards tumour growth and angiogenesis in preclinical models of GBM and melanoma.

Wang J, Svendsen A, Kmiecik J, Immervoll H, Skaftnesmo KO, Planagumà J, Reed RK, Bjerkvig R, Miletic H, Enger PØ, Rygh CB, Chekenya M.

PLoS One. 2011;6(7):e23062. doi: 10.1371/journal.pone.0023062. Epub 2011 Jul 29.

19.

Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma.

Planagumà J, Liljeström M, Alameda F, Bützow R, Virtanen I, Reventós J, Hukkanen M.

Hum Pathol. 2011 Jan;42(1):57-67. doi: 10.1016/j.humpath.2010.01.025. Epub 2010 Oct 20.

PMID:
20970160
20.

Filamin a binds to CCR2B and regulates its internalization.

Minsaas L, Planagumà J, Madziva M, Krakstad BF, Masià-Balagué M, Katz AA, Aragay AM.

PLoS One. 2010 Aug 17;5(8):e12212. doi: 10.1371/journal.pone.0012212.

21.

Cytoplasmic Prep1 interacts with 4EHP inhibiting Hoxb4 translation.

Villaescusa JC, Buratti C, Penkov D, Mathiasen L, Planagumà J, Ferretti E, Blasi F.

PLoS One. 2009;4(4):e5213. doi: 10.1371/journal.pone.0005213. Epub 2009 Apr 13.

22.

Novel molecular profiles of endometrial cancer-new light through old windows.

Doll A, Abal M, Rigau M, Monge M, Gonzalez M, Demajo S, Colás E, Llauradó M, Alazzouzi H, Planagumá J, Lohmann MA, Garcia J, Castellvi S, Ramon y Cajal J, Gil-Moreno A, Xercavins J, Alameda F, Reventós J.

J Steroid Biochem Mol Biol. 2008 Feb;108(3-5):221-9. Epub 2007 Sep 15. Review.

PMID:
18061438
23.

ERM/ETV5 up-regulation plays a role during myometrial infiltration through matrix metalloproteinase-2 activation in endometrial cancer.

Monge M, Colas E, Doll A, Gonzalez M, Gil-Moreno A, Planaguma J, Quiles M, Arbos MA, Garcia A, Castellvi J, Llaurado M, Rigau M, Alazzouzi H, Xercavins J, Alameda F, Reventos J, Abal M.

Cancer Res. 2007 Jul 15;67(14):6753-9.

24.

Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax).

de la Torre FJ, García A, Gil-Moreno A, Planaguma J, Reventos J, Ramón y Cajal S, Xercavins J.

Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):121-8. Epub 2006 Jul 28.

PMID:
16876311
25.

The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma.

Planagumà J, Gonzalez M, Doll A, Monge M, Gil-Moreno A, Baró T, García A, Xercavins J, Alameda F, Abal M, Reventós J.

Hum Pathol. 2006 Aug;37(8):1050-7. Epub 2006 Jun 23.

PMID:
16867868
26.

Molecular pathology of endometrial carcinoma: transcriptional signature in endometrioid tumors.

Abal M, Planaguma J, Gil-Moreno A, Monge M, Gonzalez M, Baro T, Garcia A, Castellvi J, Ramon Y Cajal S, Xercavins J, Alameda F, Reventos J.

Histol Histopathol. 2006 Feb;21(2):197-204. doi: 10.14670/HH-21.197. Review.

PMID:
16329044
27.

Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.

Planagumà J, Abal M, Gil-Moreno A, Díaz-Fuertes M, Monge M, García A, Baró T, Xercavins J, Reventós J, Alameda F.

J Pathol. 2005 Dec;207(4):422-9.

PMID:
16175655
28.

A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma.

Planagumà J, Díaz-Fuertes M, Gil-Moreno A, Abal M, Monge M, García A, Baró T, Thomson TM, Xercavins J, Alameda F, Reventós J.

Cancer Res. 2004 Dec 15;64(24):8846-53.

29.

Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells.

Díaz VM, Planaguma J, Thomson TM, Reventós J, Paciucci R.

Gastroenterology. 2002 Mar;122(3):806-19. Erratum in: Gastroenterology. 2003 May 12;124(5):1568. Gastroenterology 2002 Jul;123(1):397.

PMID:
11875015

Supplemental Content

Loading ...
Support Center